Nnadozie Gabriel C.: Understanding Hemophilia – Modern Breakthroughs and the Gap in Global Access
Nnadozie Gabriel C., Founder at TRiBE HQ, shared a post on LinkedIn:
“Hemophilia: When The Blood Struggles to Clot
What happens when a small cut refuses to stop bleeding?
For someone living with hemophilia, the problem is not that they have too much blood.
Their blood is missing or has very low levels of an important clotting factor needed to stop bleeding properly.
There are two common types:
- Hemophilia A: Factor VIII is low or missing.
- Hemophilia B: Factor IX is low or missing.
These factors help the body form a strong blood clot.
Without enough of them, bleeding can last longer than normal and may sometimes occur internally, especially in the joints and muscles.
Why does it mostly affect males?
Hemophilia A and B are usually X-linked inherited conditions. This means the faulty gene is carried on the X chromosome.
Because males have only one X chromosome, inheriting the faulty gene can result in hemophilia.
Females have two X chromosomes and are more commonly carriers, although females can also have hemophilia in certain circumstances.
Can hemophilia be treated?
Yes.
There is currently no simple permanent cure for most inherited cases, but effective treatments can greatly reduce bleeding and help people live active lives.
Treatment can include:
- Clotting-factor replacement: replacing the missing Factor VIII or IX.
- Other medicines: some treatments help the body produce or maintain clotting activity.
- Gene therapy: for some eligible patients, gene therapy can provide a functional copy of the affected gene and potentially reduce the need for regular factor treatment. However, eligibility, availability, cost, and long-term outcomes remain important considerations.
What can we do?
Hemophilia is not simply a medical issue. It is also an issue of awareness, access, and affordability.
We need:
- Earlier diagnosis
- Better access to treatment
- Affordable clotting-factor therapy
- Genetic counselling for affected families
- Greater public awareness
- Stronger healthcare systems and specialist care
Most importantly, people living with hemophilia should not be defined by their condition.
With appropriate care, they can learn, work, study, build families, pursue their ambitions, and live productive lives.
Understanding the condition is the first step.
Access to proper care is the next.
As future healthcare professionals and members of society, we can help turn knowledge into better outcomes.
Repost if you value healthcare and awareness, someone might need this information right now.
Let’s learn, educate, advocate and save lives…”
Stay updated with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support